Hosted on MSN44m
Report Reveals Billions Made from Generic Drug Price HikesA recent Federal Trade Commission report highlights a concerning trend in the pharmaceutical industry, where pharmacy benefit ...
Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.
According to FTC’s latest report, units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly ...
In his first public remarks since the murder of UnitedHealthcare CEO Brian Thompson last month and the backlash against the ...
Our narrow economic moat rating for UnitedHealth Group reflects our generally narrow-moat view of the US health insurance and PBM industries that includes an unclear outlook for economic profitability ...
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands ...
UnitedHealth Group (UHG) has been overcharging some cancer patients by more than 1,000 percent for live-changing drugs, a ...
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
UnitedHealth posted a better-than-expected profit in the final quarter of 2024, but a nagging rise in medical costs and care ...
UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...
The UnitedHealth Group is overcharging patients for necessary life-saving drugs as a result of price gouging that increases ...
UnitedHealth Group posted mixed Q4 results, with EPS beating estimates and revenue falling short. The company reaffirmed its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback